Interferon-γ is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts

Transplantation

Volumn 67, Issue 10, 1999, Pages 1362-1365

  Ring, Guido H ^a,b   Saleem, Sohail ^a,b   Zhenhua, Dai ^a,b   Hassan, Ali Taha ^a,b   Konieczny, Bogumila T ^a,b   Baddoura, Fady K ^c   Lakkis, Fadi G ^a,b,d  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOMYCIN; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; GRAFT SURVIVAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; CELL DIVISION; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOMYCINS; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033609320     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905270-00012     Document Type: Article

References (17)

1. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart T. Multiple defects of immune cell function in mice with disrupted interferon-y genes. Science 1993; 259: 1793.
2. Saleem S, Konieczny BT, Lowry RP, Baddoura FK, Lakkis FG. Acute rejection of vascularized heart allografts in the absence of IFNγ. Transplantation 1996; 62: 1908.
3. Steiger JU, Niekerson PW, Hermle M, Thiel G, Heim MH. IFNγ receptor signaling is not required in the effector phase of the alloimmune response. Transplantation 1998; 65: 1649.
4. Billiau A. Interferon-γ: Biology and role in pathogenesis. Adv Immunol 1996; 62: 61.
5. Konieczny BT, Dai Z, Elwood ET, et al. IFNγ is critical for long term allograft survival induced by blocking the CD28 and CD40L T cell costimulation pathways. J Immunol 1998; 160: 2059.
6. Kohn HI, Klein J, Melvold RW, Nathenson SG, Pious D, Shreffler DC. The first H-2 mutant workshop. Immunogenetics 1978; 7: 279.
7. Rosenberg AS, Finbloom DS, Maniero TG, Van der Meide PH, Singer A. Specific prolongation of MHC class 2 disparate skin allografts by in vivo administration of anti-IFN-γ monoclonal antibody. J Immunol 1990; 144: 4648.
8. Peguet-Navarro J, Dalbiez-Gauthier C, Dezutter-Dambuyant C, Schmitt D. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function. Eur J Immunol 1993; 23: 376.
9. Gaspari AA, Katz SI. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol 1988; 140: 2956.
10. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483.
11. Dallman MJ, Mason DW. Induction of Ia antigens on murine epidermal cells during the rejection of skin allografts. Transplantation 1983; 36: 222.
12. + T cells is antigen specific and requires expression of target alloantigen on Ia epidermal cells. J Immunol 1989; 143: 2452.
13. Defrance T, Carayon P, Billian G, et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994; 179: 135.
14. b antigen. J Exp Med 1991; 173: 261.
15. Austyn JM, Steinman RM. The passenger leukocyte, a fresh view. Tranplant Rev 1988; 2: 139.
16. Goes N, Urmson J, Hobart M, Halloran PF. The unique role of Interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation 1996; 62: 1889.
17. Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 difference. J Exp Med 1986; 163: 998.